Name: Unity Biotechnology, Inc. Deferred Offering Costs 2017-2019
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#dissemination

Unity Biotechnology, Inc. Deferred Offering Costs

Unity Biotechnology, Inc. had Deferred Offering Costs of $0 as of 2019-03-31, per its 10-Q filed 2019-05-08.

Discontinued › Balance Sheet › Assets › Assets, Current

us-gaap:DeferredOfferingCosts · last filed 2019-05-08

2019-03-31: Deferred Offering Costs $0.00.
2018-06-30: Deferred Offering Costs $0.00.
2018-03-31: Deferred Offering Costs $1.70M; Deferred Offering Costs as first filed $1.71M.
2017-12-31: Deferred Offering Costs $0.00.

Period end	Deferred Offering Costs	Deferred Offering Costs as first filed
2019-03-31	$0.00 10-Q · filed 2019-05-08
2018-06-30	$0.00 10-Q · filed 2018-08-09
2018-03-31	$1.70M 10-Q · filed 2019-05-08	$1.71M 10-Q · filed 2018-06-07
2017-12-31	$0.00 10-Q · filed 2018-06-07